There is a newer version of this record available.

Report Open Access

An open letter to Mehra et al and The Lancet

James Watson on the behalf of 182 signatories

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="" xmlns:oai_dc="" xmlns:xsi="" xsi:schemaLocation="">
  <dc:creator>James Watson on the behalf of 182 signatories</dc:creator>
  <dc:description>Open letter to MR Mehra, SS Desai, F Ruschitzka, and AN Patel, authors of

“Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis”. Lancet. 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6. PMID: 32450107

and to Richard Horton (editor of The Lancet).</dc:description>
  <dc:subject>The Lancet</dc:subject>
  <dc:subject>Open Science</dc:subject>
  <dc:title>An open letter to Mehra et al and The Lancet</dc:title>
All versions This version
Views 152,7149,408
Downloads 96,3166,209
Data volume 44.4 GB770.0 MB
Unique views 124,7058,435
Unique downloads 85,8965,749


Cite as